Re­silience notch­es $410M in fed­er­al fi­nanc­ing to bol­ster pro­duc­tion

Bio­phar­ma man­u­fac­tur­er Re­silience has net­ted a ma­jor in­vest­ment from the US De­part­ment of De­fense.

Re­silience inked a fi­nanc­ing agree­ment for a $410 mil­lion long-term loan from the DOD, work­ing with the US In­ter­na­tion­al De­vel­op­ment Fi­nance Cor­po­ra­tion. The loan will be used to bol­ster Re­silience’s do­mes­tic bio­man­u­fac­tur­ing ca­pac­i­ty and ca­pa­bil­i­ties for sev­er­al prod­ucts, ac­cord­ing to a press re­lease. This in­cludes bi­o­log­ics such as an­ti­bod­ies, pro­teins, vac­cines and mR­NA prod­ucts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER